Cardio Diagnostics Stock Quote CDIO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.5397

Bid

0.521

Ask

0.5397

Volume

1,331,739

0.5117 Day's Range 0.552

0.19 52 Week Range 1.94

Market Cap

21.825M

Previous Close

0.5346

Open

0.52

Last Trade

1000

0.5397

(formt)

Last Trade Time

Financial Volume

$ 703,519

VWAP

0.528271

Average Volume (3m)

6,633,640

Shares Outstanding

40,439,810

Dividend Yield

PE Ratio

-2.61

Earnings Per Share (EPS)

-0.21

Revenue

17k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

Blank Checks

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

2021

Cardio Diagnostics Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $0.53. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 0.19 to $ 1.94.

Cardio Diagnostics currently has 40,439,810 shares outstanding. The market capitalization of Cardio Diagnostics is $21.62 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -2.61.

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful...

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0702	14.9520766773	0.4695	0.624	0.4121	3064670	0.53356376	CS
4	-0.0326	-5.69631312249	0.5723	0.6823	0.4028	4319358	0.56880128	CS
12	0.2833	110.491419657	0.2564	1.77	0.2301	6633640	0.74058668	CS
26	0.0897	19.9333333333	0.45	1.77	0.19	4274939	0.59385823	CS
52	-1.3303	-71.1390374332	1.87	1.94	0.19	2345946	0.62683623	CS
156	-3.7103	-87.3011764706	4.25	8.4999	0.171	3151113	1.59636055	CS
260	-3.7103	-87.3011764706	4.25	8.4999	0.171	3151113	1.59636055	CS

CDIO - Frequently Asked Questions (FAQ)

What is the current Cardio Diagnostics share price?

The current share price of Cardio Diagnostics is $ 0.5397

How many Cardio Diagnostics shares are in issue?

Cardio Diagnostics has 40,439,810 shares in issue

What is the market cap of Cardio Diagnostics?

The market capitalisation of Cardio Diagnostics is USD 21.62M

What is the 1 year trading range for Cardio Diagnostics share price?

Cardio Diagnostics has traded in the range of $ 0.19 to $ 1.94 during the past year

What is the PE ratio of Cardio Diagnostics?

The price to earnings ratio of Cardio Diagnostics is -2.61

What is the cash to sales ratio of Cardio Diagnostics?

The cash to sales ratio of Cardio Diagnostics is 1.35k

What is the reporting currency for Cardio Diagnostics?

Cardio Diagnostics reports financial results in USD

What is the latest annual turnover for Cardio Diagnostics?

The latest annual turnover of Cardio Diagnostics is USD 17k

What is the latest annual profit for Cardio Diagnostics?

The latest annual profit of Cardio Diagnostics is USD -8.38M

What is the registered address of Cardio Diagnostics?

The registered address for Cardio Diagnostics is 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

Which industry sector does Cardio Diagnostics operate in?

Cardio Diagnostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSATGlobalstar Inc	$ 21.05 (5,162.50%)	1.58M
TIVCTivic Health Systems Inc	$ 0.696717 (196.48%)	509.57M
SHOTWSafety Shot Inc	$ 0.4537 (143.14%)	6.73k
MYNAMynaric AG	$ 0.6152 (132.50%)	77.77M
KDLYKindly MD Inc	$ 3.26 (129.32%)	219.17M
ALCEAlternus Clean Energy Inc	$ 0.058 (-74.34%)	3.36M
MSWMing Shing Group Holdings Ltd	$ 3.0267 (-46.43%)	1.25M
TTOOT2 Biosystems Inc	$ 0.0784 (-41.49%)	5.84M
ATOMAtomera Incorporated	$ 5.315 (-38.55%)	4.29M
OTLYOatly Group AB	$ 0.394 (-32.62%)	30.93M
TIVCTivic Health Systems Inc	$ 0.696717 (196.48%)	509.57M
CYNCYNGN Inc	$ 0.1491 (-8.53%)	325.57M
KDLYKindly MD Inc	$ 3.26 (129.32%)	219.17M
NXUNXU Inc	$ 0.41 (49.69%)	184.67M
ADTXAditxt Inc	$ 0.0897 (-5.78%)	181.67M